Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001171843-25-006551
Filing Date
2025-10-21
Accepted
2025-10-21 09:16:58
Documents
15
Period of Report
2025-10-21

Document Format Files

Seq Description Document Type Size
1 FORM 6-K f6k_102125.htm 6-K 48699
2 GRAPHIC f6k_01.jpg GRAPHIC 114216
3 GRAPHIC f6k_02.jpg GRAPHIC 85158
4 GRAPHIC f6k_03.jpg GRAPHIC 149455
5 GRAPHIC f6k_04.jpg GRAPHIC 246957
6 GRAPHIC f6k_05.jpg GRAPHIC 442880
7 GRAPHIC f6k_06.jpg GRAPHIC 465677
8 GRAPHIC f6k_07.jpg GRAPHIC 70344
9 GRAPHIC f6k_08.jpg GRAPHIC 422545
10 GRAPHIC f6k_09.jpg GRAPHIC 285778
11 GRAPHIC f6k_10.jpg GRAPHIC 275053
12 GRAPHIC f6k_11.jpg GRAPHIC 308673
13 GRAPHIC f6k_12.jpg GRAPHIC 142598
14 GRAPHIC logo.jpg GRAPHIC 77729
15 GRAPHIC ca.jpg GRAPHIC 24896
  Complete submission text file 0001171843-25-006551.txt   4337920
Mailing Address NOVO ALLE DK 2880 BAGSVAERD DENMARK G7 00000
Business Address NOVO ALLE DK 2880 BAGSVAERD DENMARK G7 00000 4544448888
NOVO NORDISK A S (Filer) CIK: 0000353278 (see all company filings)

EIN.: 000000000 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 333-82318 | Film No.: 251405499
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)